Syncom Pharmaceuticals Inc is categorized under Dairy and Non-Dairy Based Dietary Supplements in Fairfield, NJ and active since 1987.
Syncom Pharmaceuticals Inc was established in 1987, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Dairy and Non-Dairy Based Dietary Supplements business, which does work in the BOTH market, and is classified as a Dairy and Non-Dairy Based Dietary Supplements, under code number 311514 by the NAICS.
If you are seeking more information, feel free to contact James W De Coursin at the company’s headquarters by writing to , Fairfield, New Jersey NJ 07004 or by phoning (973) 787-2405. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Syncom Pharmaceuticals Inc |
Contact Person: | James W De Coursin |
Phone Number: | (973) 787-2405 |
Website Address: | syncom.net |
Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
Founded: | 1987 |
Location Type: | Headquarters |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | Dairy and Non-Dairy Based Dietary Supplements |
SIC Code: | 2023 |
NAICS Code: | 311514 |
Share This Business: |
Syncom Pharmaceuticals Inc was started in 1987 to provide professional Dairy and Non-Dairy Based Dietary Supplements under the SIC code 2023 and NAICS code 311514. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact James W De Coursin for inquiries that concern Syncom Pharmaceuticals Inc by calling the company number (973) 787-2405, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Syncom Pharmaceuticals Inc can be found at the coordinates 40.87886,-74.29647 as well as the street address in Fairfield, New Jersey 07004.
For its online presence, you may visit Syncom Pharmaceuticals Inc’s website at syncom.net and engage with its social media outlets through on Twitter and on Facebook.